Cys340Ser Mutation Abolishing S-Nitrosylation Drives GRK2 Mitochondrial Localization and Dysfunction

Area of Science:

• Cardiovascular Biology
• Mitochondrial Medicine
• Molecular Cardiology

Background:

• G protein-coupled receptor kinase 2 (GRK2) is upregulated in cardiac pathologies.
• GRK2 contributes to cardiac dysfunction through both receptor-mediated and mitochondrial effects.
• S-nitrosylation of GRK2 at Cysteine 340 acts as an endogenous brake on its activity.

Purpose of the Study:

• To investigate the role of S-nitrosylation in regulating GRK2's mitochondrial localization and function.
• To examine GRK2's impact on mitochondrial dynamics and mitophagy under hypoxia/reoxygenation stress.

Main Methods:

• Utilized AC16 cardiac cells infected with adenoviruses expressing a GRK2 C340S mutation to block S-nitrosylation.
• Assessed mitochondrial function via oxygen consumption rates and ATP production.
• Analyzed mitochondrial dynamics and mitophagy.

Main Results:

• Inhibition of S-nitrosylation significantly enhanced GRK2's mitochondrial localization, particularly under pathological conditions.
• Mitochondrial function, including oxygen consumption and ATP production, was impaired when S-nitrosylation was blocked.
• GRK2 without S-nitrosylation led to adverse outcomes due to altered mitochondrial dynamics and mitophagy.

Conclusions:

• S-nitrosylation is crucial for regulating GRK2's mitochondrial function and localization in cardiac cells.
• Disrupting GRK2 S-nitrosylation exacerbates mitochondrial dysfunction and adverse cardiac outcomes.
• Targeting GRK2 post-translational modifications, like S-nitrosylation, presents a potential therapeutic strategy for cardiac pathologies.